Paul J. Clancy, Executive VP and CFO at BIOGEN IDEC INC. (BIIB), sold 1,553 shares at $50.00 ($78K) on 2008-09-19, disclosed to the SEC on 2008-09-23.
Scheduled sale ($78k) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ALXN | SELL | 2018-02-08 | $1.4M | — | Filing → |
| BIIB | SELL | 2017-04-27 | $2.9M | — | Filing → |
| BIIB | SELL | 2017-03-14 | $5.8M | — | Filing → |